Market Wizard
12.8K subscribers
63.8K photos
11 videos
1.16K files
21.3K links
FREE FINANCIAL EDUCATIONAL CHANNEL

Disclaimer : We are not SEBI Registered. Please consult your financial advisor before investing.

All the posts appearing in the channel are only for educational and informational purposes.

ALL RIGHTS RESERVED!!!
Download Telegram
*Results on May 18*
Tata Motors, Canara Bank, Aarti Industries, Abbott India, Torrent Pharmaceuticals, Ujjivan Small Finance Bank, Arfin India, Astral, Biogen Pharmachem Industries, Brigade Enterprises, Century Enka, Chalet Hotels, Coromandel Engineering Company, Diamines & Chemicals, Dolat Investments, Ester Industries, GSK Pharma, Gujarat Alkalies & Chemicals, Gulshan Polyols, IIFL Wealth Management, JBM Auto, Jindal Stainless (Hisar), JSL Industries, Jyothy Labs, Kalyani Investment Company, Kalyani Steels, Minda Corporation, PI Industries, Pioneer Embroideries, Route Mobile, Shilp Gravures, Umang Dairies, Upsurge Investment & Finance, and Xtglobal Infotech will release quarterly earnings scorecard on May 18.
*Stocks To Watch*

Bharat Forge: To purchase a 49% stake in its subsidiary, Kalyani Strategic Systems, for Rs 32.97 crore. Currently, the company holds a 51% stake in KSSL. After this acquisition, KSSL shall become a wholly-owned subsidiary of the company.

HCL Technologies: Announced expansion of investment in the United Kingdom with the hiring of 1000 technology professionals to support its clients in the U.K. and around the world.

Zuari Agro Chemicals: Company said its Goa fertiliser plant has been hit by the cyclonic storm Tauktae. It is assessing damages by the cyclone to the plant. There could be a potential delay in restarting ammonia, urea plants.

Apollo Tyres: Company says the Perambra plant in Kerala will be closed till May 23 in view of the local restrictions due to Covid-19.

Union Bank of India: Board approved raising up to Rs 1,750 crore through a qualified institutional placement at a floor price of Rs 35.6 per share. The share sale was authorised to open on May 17.

Kotak Mahindra Bank: Acquired 1.3 crore equity shares, representing 46.7% of the issued and paid-up equity share capital of Kotak Mahindra Pension Fund Limited from Kotak Mahindra Asset Management Company Limited for Rs 12.71 crore. After this acquisition, the bank's shareholding in KMPFL will increase from 4.3% to 51%. Also, KMPFL has now become a direct subsidiary of the bank.

Garden Reach Shipbuilders And Engineers: Suspended operations at all units in West Bengal till May 30 to comply with state Covid order.

Strides Pharma Sciences: Promoter pledge reduced by 38%. Currently, the overall promoter group pledge stands at 25.98% of the promoter holding and 7.71% of the paid-up capital of the company as compared to 41.96% of the promoter holding and 12.45% of the paid-up capital as of May 7.

Hemisphere Properties India: Board has allotted 10 crore Non-Cumulative Redeemable Preference Shares of Rs 10 each at par aggregating to Rs 100 crore on a private placement basis to the Promoter President of India

Skipper: To keep its offices and manufacturing units in West Bengal shut till May 30 to comply with state Covid order.
*Results on May 18*

Tata Motors, Canara Bank, Aarti Industries, Abbott India, Torrent Pharmaceuticals, Ujjivan Small Finance Bank, Arfin India, Astral, Biogen Pharmachem Industries, Brigade Enterprises, Century Enka, Chalet Hotels, Coromandel Engineering Company, Diamines & Chemicals, Dolat Investments, Ester Industries, GSK Pharma, Gujarat Alkalies & Chemicals, Gulshan Polyols, IIFL Wealth Management, JBM Auto, Jindal Stainless (Hisar), JSL Industries, Jyothy Labs, Kalyani Investment Company, Kalyani Steels, Minda Corporation, PI Industries, Pioneer Embroideries, Route Mobile, Shilp Gravures, Umang Dairies, Upsurge Investment & Finance, and Xtglobal Infotech will release quarterly earnings scorecard on May 18
Macquarie on Solara Pharma
Added to Asia Marquee Buy list
Catalyst: Vizag facility reaching optimal utilisation in 1QFY22, further clarity on Aurore merger synergy benefits
MS on AB Capital
OW, TP raised to Rs 158
PBT & PAT 19% & 30%, respectively, above MSe
Co seeing structural profitability expansion across biz
Conviction of it becoming a 15%+ annual compounder is rising; this, along with its parentage, make a potent combination for re-rating
CLSA on CIPLA
Weak quarter despite adjustments
Covid-19 products & monetisation of US inhaler pipeline key catalysts
Weak qtr with a miss across sales, Ebitda & net profit
Growth was rather muted across geographies
Raise 22-23CL EPS by 2-3%
CLSA on drreddys
Miss in 4Q but strong outlook
25% Ebitda margin goal achievable in 2-3yrs on sustainable basis (By FY24)
Strong performance in India, the EU and ROW & a steady quarter for the US
Raise our FY22/23CL EPS by 9%/15%
Escorts
CS: Demand bounceback in 2H + strong mid-term drivers of margin & market share gains
Medium-term strategy remains on track with focus on share gain in South, ramp up of capacity & boosting
exports through Kubota channel